TREACE MEDICAL CONCEPTS INC (TMCI)

US89455T1097 - Common Stock

7.79  -0.11 (-1.39%)

After market: 7.79 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
202.86M187.12M141.80M94.40M57.40M
Cost Of Goods
39.33M35.18M27.50M17.80M12.50M
Gross Profit
163.53M151.94M114.30M76.60M44.90M
Operating Expenses
225.80M203.37M149.20M93.10M44.00M
Research and Development
19.53M15.44M13.60M10.20M5.80M
Selling, General, and Administrative Expenses
206.26M187.93M135.60M82.90M38.20M
Operating Income
-62.27M-51.43M-34.80M-16.50M900.00K
Interest Income/Expense
441.00K1.56M-3.20M-4.00M-4.50M
Other Income/Expense
302.00K342.00KN/AN/AN/A
Non Recurring Items
N/A0.00-4.80MN/AN/A
Income Before Taxes
-61.52M-49.53M-42.80M-20.60M-3.70M
Net Income
-61.52M-49.53M-42.80M-20.70M-4.30M
EBITDA
-54.31M-46.08M-32.67M-15.81M2.11M
 
Per Share Data
EPS Diluted Total Ops
-0.99-0.81-0.77-0.43-0.09
Non GAAP EPS
-0.94-0.81-0.77-0.41N/A
 
Statistics
Gross Profit Margin
80.61%81.20%80.61%81.14%78.22%
Profit Margin
-30.33%-26.47%-30.18%-21.93%-7.49%
Operating Profit Margin
-30.69%-27.48%-24.54%-17.48%1.57%

All data in USD

Charts